Insperity Q2 Earnings: -$5mln Loss, $1.658bln Revenue, $0.26 EPS
PorAinvest
viernes, 1 de agosto de 2025, 9:30 am ET1 min de lectura
NSP--
The primary driver of Insperity's underperformance was a 14% decline in gross profit, largely attributed to surging healthcare costs. Elevated pharmacy trends and large claim activity eroded margins despite the revenue growth [1]. The company's year-to-date gross profit dropped 12% to $533 million, highlighting the sector-wide strain [1].
Despite the earnings miss, Insperity's management remains optimistic about the company's long-term prospects. The company's chairman and CEO, Paul J. Sarvadi, stated that recent growth momentum and strategic plans lay the foundation for accelerated growth and improved profitability in 2026. The company also announced a targeted go-live date for Insperity HRScale, a joint solution with Workday, in early 2026, signaling a shift toward technology-driven growth [3].
For the third quarter of 2025, Insperity forecast adjusted EPS between $0.06 and $0.49, compared to the analyst consensus of $0.31. For the full fiscal year 2025, the company expects adjusted EPS of $1.81 to $2.51, with the midpoint of $2.16 falling below the analyst consensus of $2.48 [2].
Insperity's strategic response includes pricing adjustments, benefit redesign, and a partnership with Workday to develop Insperity HRScale. The company returned $64 million to shareholders during the first six months of 2025 through share repurchases and dividends [3].
References:
- [1] https://www.ainvest.com/news/insperity-q2-earnings-temporary-setback-deeper-challenge-2508/
- [2] https://www.investing.com/news/earnings/insperity-shares-fall-6-as-guidance-disappoints-following-q2-earnings-miss-93CH-4165905
- [3] https://www.stocktitan.net/news/NSP/insperity-announces-second-quarter-0q2t7woeidvv.html
WDAY--
Insperity Inc. reported Q2 earnings of -$5 million, compared to $18 million in the same period last year. EPS was -$0.14, down from $0.48 YoY. Adjusted EPS was $0.26, beating analysts' expectations of $0.41. Revenue increased to $1.658 billion from $1.605 billion YoY. The company provided EPS guidance of $0.06-$0.49 for Q3 and $1.81-$2.51 for FY22.
Insperity Inc. (NYSE: NSP) reported a net loss of $5 million for the second quarter of 2025, marking a significant decline from the $18 million net income reported in the same period last year. The company's earnings per share (EPS) dropped to -$0.14, down from $0.48 year-over-year (YoY), while adjusted EPS came in at $0.26, which was slightly above analysts' expectations of $0.41. Revenue increased to $1.658 billion, up 3% from $1.605 billion YoY.The primary driver of Insperity's underperformance was a 14% decline in gross profit, largely attributed to surging healthcare costs. Elevated pharmacy trends and large claim activity eroded margins despite the revenue growth [1]. The company's year-to-date gross profit dropped 12% to $533 million, highlighting the sector-wide strain [1].
Despite the earnings miss, Insperity's management remains optimistic about the company's long-term prospects. The company's chairman and CEO, Paul J. Sarvadi, stated that recent growth momentum and strategic plans lay the foundation for accelerated growth and improved profitability in 2026. The company also announced a targeted go-live date for Insperity HRScale, a joint solution with Workday, in early 2026, signaling a shift toward technology-driven growth [3].
For the third quarter of 2025, Insperity forecast adjusted EPS between $0.06 and $0.49, compared to the analyst consensus of $0.31. For the full fiscal year 2025, the company expects adjusted EPS of $1.81 to $2.51, with the midpoint of $2.16 falling below the analyst consensus of $2.48 [2].
Insperity's strategic response includes pricing adjustments, benefit redesign, and a partnership with Workday to develop Insperity HRScale. The company returned $64 million to shareholders during the first six months of 2025 through share repurchases and dividends [3].
References:
- [1] https://www.ainvest.com/news/insperity-q2-earnings-temporary-setback-deeper-challenge-2508/
- [2] https://www.investing.com/news/earnings/insperity-shares-fall-6-as-guidance-disappoints-following-q2-earnings-miss-93CH-4165905
- [3] https://www.stocktitan.net/news/NSP/insperity-announces-second-quarter-0q2t7woeidvv.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios